Concord Drugs Q1 Results

  • BSE: 538965
  • NSE: -
  • ISIN: INE858L01010
  • Sector: Biotechnology & Drugs
BSE
35.2-0.80 (-2.22%)
Volume6.78 K
Updated: Tue 26 Nov, 2024 | 15:10:47
NSE
This stock is not traded on NSE
Today: 35.00
37.90
52-Wk: 30.59
61.50

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Concord Drugs Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 11.6912.31-%8.98-%
    Selling/ General/ Admin Expenses Total 1.461.30-%1.38-%
    Depreciation/ Amortization 0.340.33-%0.38-%
    Other Operating Expenses Total 0.38-0.75-%0.35-%
    Total Operating Expense 11.2011.67-%7.91-%
    Operating Income 0.490.64-%1.08-%
    Net Income Before Taxes 0.040.14-%0.64-%
    Net Income 0.030.16-%0.49-%
    Diluted Normalized EPS 0.030.15-%0.53-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts